Kelsey Jensen

Kelsey Jensen

Auto-generated profile, based on publicly available information

Kelsey Jensen

Mayo Clinic Health System

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
DIDan Ilges
Dan Ilges
KJKelsey Jensen
Kelsey Jensen
EDEvan Draper
Evan Draper
RDRoss Dierkhising
Ross Dierkhising
KPKimberly A Prigge
Kimberly A Prigge
RSRyan W. Stevens
Ryan W. Stevens
To evaluate the frequency of unnecessary antibiotic prescribing for Tier 3 respiratory infection (URI) syndromes across the Mayo Clinic Enterprise before and after a multifaceted antimicrobial stewardship intervention, and to determine ongoing factors associated with antibiotic prescribing and repeat respiratory healthcare contact in the post-intervention period. This was a quasi-experimental, pre/post, retrospective cohort study from January 1st, 2019– December 31st, 2022, with 12-month washout during implementation from July 1st, 2020–June 30th, 2021. All outpatient encounters, adult and pediatric, from primary care, urgent care, and emergency medicine specialties with a Tier 3 URI diagnosis were included. The intervention was a multifaceted outpatient antibiotic stewardship bundle. The primary outcome was the rate of antibiotic prescribing in Tier 3 encounters. Secondary outcomes included 14-day repeat healthcare contact for respiratory indications and factors associated with persistent unnecessary prescribing. 165,658 Tier 3 encounters, 96,125 in the pre- and 69,533 in the post-intervention period, were included. Following intervention, the prescribing rate for Tier 3 encounters decreased from 21.7% to 11.2% (P<0.001). Repeat 14-day respiratory healthcare contact in the no antibiotic group was lower post-intervention (9.9.% vs 9.4%, P=.004). Multivariable models indicated that increasing patient age, Charlson comorbidity index, and primary diagnosis selected were the most important factors associated with persistent unnecessary antibiotic prescribing. Outpatient antibiotic stewardship initiatives can reduce unnecessary antibiotic prescribing for Tier 3 URIs without increasing repeat respiratory healthcare contact. Advancing age and number of comorbidities remain risk factors for persistent unnecessary antibiotic prescribing.

2 August 2023 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
KJKelsey Jensen
Kelsey Jensen
OSOmar Abu Saleh
Omar Abu Saleh
SCSupavit Chesdachai
Supavit Chesdachai
PJPaul J Jannetto
Paul J Jannetto
KMKristin C Mara
Kristin C Mara
CRChristina G Rivera
Christina G Rivera
Posaconazole therapeutic drug monitoring (TDM) is widely utilized to assess therapeutic efficacy and safety; however, clinical effects of very high serum concentrations are unknown. A retrospective review of 90 patients receiving posaconazole for treatment or prophylaxis of invasive fungal infections with serum concentrations ≥3000 ng/mL from 1/1/2019-4/30/2021 evaluated the incidence and type of adverse drug reactions (ADR). Symptomatic ADRs were very common in patients with posaconazole concentrations of ≥5000 ng/mL and 3000-4999 ng/mL (80% vs. 58.8%; p = 0.31). Posaconazole TDM should be performed for both treatment and prophylaxis indications and dose decrease for serum concentrations >3000 ng/mL should be considered. Drug level monitoring is commonly used to evaluate appropriate dosing and effectiveness of posaconazole, a medication used to treat fungal infections. Patients with high levels commonly had side effects. Posaconazole monitoring should be completed, and doses reduced when levels are high.

23 September 2021 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
KJKelsey L. Jensen
Kelsey L. Jensen
CRChristina Rivera
Christina Rivera
EDEvan W. Draper
Evan W. Draper
SASara E. Ausman
Sara E. Ausman
BABenjamin J. Anderson
Benjamin J. Anderson
RSRyan W. Stevens
Ryan W. Stevens

18 January 2024 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
RSRyan W. Stevens
Ryan W. Stevens
JMJames Manz
James Manz
MMMargo Mathre
Margo Mathre
NBNatalie Bell
Natalie Bell
AVAbinash Virk
Abinash Virk
KJKelsey Jensen
Kelsey Jensen

21 April 2025 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
MNMatt Neumann
Matt Neumann
RSRyan W. Stevens
Ryan W. Stevens
KCKristin Cole
Kristin Cole
Paschalis VergidisPaschalis Vergidis
Paschalis Vergidis
AVAbinash Virk
Abinash Virk
KJKelsey L. Jensen
Kelsey L. Jensen
Background: Optimizing antibiotic prescribing for urinary tract infections (UTI) represents an opportunity for ambulatory antibiotic stewardship programs (ASPs). A pre-populated order panel for UTI was implemented in the Mayo Clinic Enterprise in May 2022. The order panel provides antibiotic regimens aligning with institutional guidelines according to patient characteristics, presence or absence of complicating features, and antimicrobial allergy status. We assessed impacts of panel use on prescribing practices for cystitis. Methods: This retrospective cohort study of ambulatory encounters with a primary diagnosis of cystitis from May 16, 2022, to May 15, 2023, compared encounters in which the order panel was utilized to encounters managed without the panel. The primary outcome was concordance with institutional guidelines, including drug selection, dose/frequency, and duration. Secondary outcomes included rate of repeat healthcare contact for UTI within 14 days and total duration of therapy. Results: 793 randomly selected patient encounters (397 panel and 396 non-panel) were included. Prescribing was guideline adherent in 79.3% and 64.9% (P < 0.001) of panel and non-panel encounters, respectively. There were more 3- and 5-day treatment courses in the panel cohort; however, inappropriate duration of therapy was the most common reason for non-concordance in both cohorts. There was no significant difference between groups in repeat 14-day healthcare contact for UTI (13.4% panel vs 11.1% no panel, P = 0.34). Conclusion: Use of a pre-populated ambulatory order panel for the treatment of cystitis was associated with greater concordance with institutional guidelines, without adversely impacting repeat healthcare contact for UTI.

5 August 2022 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
KHKellie N. Arensman Hannan
Kellie N. Arensman Hannan
EDEvan W. Draper
Evan W. Draper
KUKaren A. Uecker-Bezdicek
Karen A. Uecker-Bezdicek
EGEric O. Gomez-Urena
Eric O. Gomez-Urena
KJKelsey L. Jensen
Kelsey L. Jensen
A multimodal antimicrobial stewardship intervention was associated with a decrease in antibiotic prescribing for targeted non–coronavirus disease 2019 (COVID-19) upper respiratory infections from 27.6% in 2019 to 7.6% in 2021. We describe our approach to prioritizing departments for 3 levels of interventions in the setting of limited stewardship personnel.